Creative Medical Technology Holdings (CELZ) Restructuring Costs (2010 - 2015)
Creative Medical Technology Holdings (CELZ) posted quarterly Restructuring Costs of $925.0 for Q4 2015, up 60.87% year-over-year from $575.0 in Q4 2014, and up 825.0% quarter-over-quarter from $100.0 in Q1 2015.
Creative Medical Technology Holdings (CELZ) Restructuring Costs (2010 - 2015) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Restructuring Costs for 6 consecutive years, with $925.0 the latest figure, recorded in Q4 2015.
- In Q4 2015, Restructuring Costs rose 60.87% year-over-year to $925.0; the TTM figure through Mar 2016 stood at $925.0 (up 19.35% YoY), while the FY2015 annual figure was $1025.0, up 36.67% from the prior year.
- Restructuring Costs improved to $925.0 in Q4 2015 per CELZ's latest filing, from $100.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $925.0 in Q4 2015 and bottomed at $75.0 in Q1 2014.
- Historically, Restructuring Costs has averaged $424.5 across 5 years, with a median of $384.5 in 2011.
- Annual changes were most pronounced in 2011 — Restructuring Costs jumped 596.72% — and 2012, when it plunged 48.45%.
- Creative Medical Technology Holdings' Restructuring Costs stood at $850.0 in 2011, then dropped by 11.76% to $750.0 in 2012, then fell by 23.33% to $575.0 in 2013, then changed by 0.0% to $575.0 in 2014, then jumped by 60.87% to $925.0 in 2015.
- Business Quant data shows CELZ's Restructuring Costs at $925.0 in Q4 2015, $100.0 in Q1 2015, and $575.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 925.00 |
| Mar 31, 2015 | 100.00 |
| Dec 31, 2014 | 575.00 |
| Jun 30, 2014 | 100.00 |
| Mar 31, 2014 | 75.00 |
| Dec 31, 2013 | 575.00 |
| Jun 30, 2013 | 100.00 |
| Dec 31, 2012 | 750.00 |
| Jun 30, 2012 | 100.00 |
| Dec 31, 2011 | 850.00 |
| Jun 30, 2011 | 194.00 |
| Mar 31, 2011 | 750.00 |
| Dec 31, 2010 | 122.00 |